Stay updated on EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer

Sign up to get notified when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.
Latest website image capture
Clouds background image

Latest updates to the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing v3.3.3; no other content changes are evident.
    Difference
    0.0%
    Check dated 2026-01-14T03:47:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A consolidated 'Locations' section lists study sites by state (Arizona, California, Colorado, Delaware, Florida, Georgia, Illinois, Kentucky, Massachusetts, New York, North Carolina, Pennsylvania, Tennessee, Texas, Virginia), replacing the previous 'State Locations' entries; the page revision updates to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T21:48:49.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The PubMed publications description was simplified from a statement that publications are automatically created by ClinicalTrials.gov using the NCT number to a note that PubMed publications are automatically filled from PubMed and may not be about the study; the revision version is updated to Rev. 3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:26:06.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page previously displayed a government funding status notice; that notice has been removed without altering trial data, eligibility criteria, endpoints, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T07:11:58.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The two screenshots of the Study Details page show only minor layout and wording adjustments; core study information such as title, interventions, primary and secondary outcomes, eligibility criteria, and enrollment remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:21:00.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Update includes a critical operating-status notice and an upgraded version identifier to v3.2.0, replacing the previous v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:35:35.000Z thumbnail image

Stay in the know with updates to EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer

Enter your email address, and we'll notify you when there's something new on the EAGLE Clinical Trial: MEDI4736 & Tremelimumab in Head & Neck Cancer page.